Regeneron Pharmaceuticals - 27 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Regeneron Pharmaceuticals as of November 16, 2018 is 345.33.
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 350.2286 382.6000 408.5100 284.6000 345.3300 -8.15%
2017 422.4830 379.7000 526.5300 340.7500 375.9600 2.42%
2016 394.5000 516.5500 519.4800 331.0500 367.0900 -32.38%
2015 498.7331 410.1600 592.4000 396.8900 542.8700 32.33%
2014 333.6675 274.5900 434.9500 267.6200 410.2500 49.05%
2013 239.8612 181.2000 316.6320 158.4200 275.2400 60.89%
2012 130.8339 56.4300 187.7400 56.4300 171.0700 208.62%
2011 51.1067 33.8200 72.1900 32.6100 55.4300 68.84%
2010 26.2129 24.6300 33.6900 20.7900 32.8300 35.77%
2009 17.7172 18.7000 24.7400 12.0500 24.1800 31.70%
2008 18.9787 23.5600 24.7500 13.3500 18.3600 -23.98%
2007 20.5494 19.8100 28.6000 13.6600 24.1500 20.33%
2006 16.1155 15.9000 24.2800 11.1200 20.0700 26.23%
2005 8.2982 9.0400 16.8300 4.6300 15.9000 72.64%
2004 10.8352 15.0500 16.7200 6.8500 9.2100 -37.39%
2003 14.7557 19.0900 22.3050 5.8800 14.7100 -20.53%
2002 18.8848 27.9200 29.3100 11.3600 18.5100 -34.27%
2001 28.3779 35.5600 39.0000 20.6000 28.1600 -20.16%
2000 27.3401 12.3100 56.5000 11.6300 35.2700 176.63%
1999 7.8169 7.9380 12.7500 5.5630 12.7500 72.88%
1998 8.1477 8.8750 10.9400 5.8750 7.3750 -13.87%
1997 9.8900 17.1300 19.3800 6.5000 8.5630 -46.88%
1996 16.2382 13.2500 24.6250 11.8750 16.1200 26.43%
1995 9.5972 3.3130 16.9400 3.3130 12.7500 325.00%
1994 7.0362 15.2500 17.2500 3.0000 3.0000 -80.65%
1993 15.5031 12.0000 21.5000 11.0000 15.5000 29.17%
1992 13.0192 18.7500 22.5000 8.0000 12.0000 -33.81%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $36.446B $5.872B
Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.301B 13.72
Gilead Sciences (GILD) United States $91.265B 10.99
Biogen (BIIB) United States $63.175B 12.79
Celgene (CELG) United States $48.689B 9.45
Illumina (ILMN) United States $45.310B 52.78
Vertex Pharmaceuticals (VRTX) United States $42.060B 73.47
Alexion Pharmaceuticals (ALXN) United States $25.904B 17.73
BioMarin Pharmaceutical (BMRN) United States $16.339B 0.00
Incyte (INCY) United States $13.652B 377.35
Seattle Genetics (SGEN) United States $8.501B 0.00
Exact Sciences (EXAS) United States $8.413B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $7.819B 25.01
Sarepta Therapeutics (SRPT) United States $7.484B 0.00
BeiGene (BGNE) Cayman Islands $6.679B 0.00
Alnylam Pharmaceuticals (ALNY) United States $6.574B 0.00
Bluebird Bio (BLUE) United States $6.371B 0.00
Bio-Techne Corp (TECH) United States $6.096B 41.18
Galapagos (GLPG) Belgium $5.286B 0.00
Alkermes (ALKS) Ireland $5.128B 3300.00
Exelixis (EXEL) United States $5.011B 14.20
Amarin (AMRN) Ireland $4.712B 0.00
Horizon Pharma Public (HZNP) Ireland $3.560B 14.65
Immunomedics (IMMU) United States $3.504B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.454B 0.00
Emergent Biosolutions (EBS) United States $3.378B 28.46
Ligand Pharmaceuticals (LGND) United States $3.141B 24.03
Guardant Health (GH) United States $3.113B 0.00
Array BioPharma (ARRY) United States $3.096B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.973B 0.00
Allogene Therapeutics (ALLO) United States $2.881B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.863B 0.00
Repligen (RGEN) United States $2.797B 87.37
Genomic Health (GHDX) United States $2.737B 92.39
Blueprint Medicines (BPMC) United States $2.466B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.447B 0.00
Akcea Therapeutics (AKCA) United States $2.408B 0.00
Ascendis Pharma (ASND) Denmark $2.357B 0.00
China Biologic Products (CBPO) China $2.315B 16.48
Acceleron Pharma (XLRN) United States $2.310B 0.00
Allakos (ALLK) United States $2.277B 0.00
Halozyme Therapeutics (HALO) United States $2.215B 49.42
Myriad Genetics (MYGN) United States $2.209B 21.89
ACADIA Pharmaceuticals (ACAD) United States $2.193B 0.00
MyoKardia (MYOK) United States $2.177B 0.00
REGENXBIO (RGNX) United States $2.115B 28.37
Amicus Therapeutics (FOLD) United States $1.938B 0.00
Global Blood Therapeutics (GBT) United States $1.876B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.804B 0.00
Reata Pharmaceuticals (RETA) United States $1.785B 0.00
AnaptysBio (ANAB) United States $1.735B 0.00
Aimmune Therapeutics (AIMT) United States $1.698B 0.00
Denali Therapeutics (DNLI) United States $1.661B 0.00
Innoviva (INVA) United States $1.638B 9.26
Arena Pharmaceuticals (ARNA) United States $1.607B 0.00
Cambrex (CBM) United States $1.604B 11.98
Atara Biotherapeutics (ATRA) United States $1.545B 0.00
Spark Therapeutics (ONCE) United States $1.540B 0.00
Medicines (MDCO) United States $1.536B 0.00
G1 THERAPEUTICS (GTHX) United States $1.503B 0.00
NeoGenomics (NEO) United States $1.488B 123.08
Rubius Therapeutics (RUBY) United States $1.460B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.435B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.352B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.320B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.306B 0.00
Editas Medicine (EDIT) United States $1.286B 0.00
Insmed (INSM) United States $1.284B 0.00
Myovant Sciences (MYOV) United Kingdom $1.274B 0.00
Mirati Therapeutics (MRTX) United States $1.211B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.172B 93.13
IMMURON LTD (IMRN) Australia $1.160B 0.00
WAVE Life Sciences (WVE) Singapore $1.129B 0.00
Lion Biotechnologies (IOVA) United States $1.084B 0.00
Solid Biosciences (SLDB) United States $1.057B 0.00
Cellectis (CLLS) France $1.015B 0.00
Momenta Pharmaceuticals (MNTA) United States $0.995B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.984B 0.00
Sangamo Therapeutics (SGMO) United States $0.971B 0.00
Retrophin (RTRX) United States $0.968B 0.00
Audentes Therapeutics (BOLD) United States $0.960B 0.00
DBV Technologies (DBVT) France $0.934B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.913B 0.00
Acorda Therapeutics (ACOR) United States $0.885B 11.20
Alder BioPharmaceuticals (ALDR) United States $0.883B 0.00
Intra-Cellular Therapies (ITCI) United States $0.868B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.857B 0.00
UniQure (QURE) Netherlands $0.850B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.845B 0.00
Puma Biotechnology (PBYI) United States $0.837B 0.00
Aptinyx (APTX) United States $0.833B 0.00
Fate Therapeutics (FATE) United States $0.821B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.820B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.804B 0.00
Clovis Oncology (CLVS) United States $0.795B 0.00
Viking Therapeutics (VKTX) United States $0.784B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.775B 0.00
Revance Therapeutics (RVNC) United States $0.771B 0.00
Apellis Pharmaceuticals (APLS) United States $0.769B 0.00
Heska (HSKA) United States $0.746B 61.09
Coherus BioSciences (CHRS) United States $0.746B 0.00
Intellia Therapeutics (NTLA) United States $0.739B 0.00
Dynavax Technologies (DVAX) United States $0.720B 0.00
Cara Therapeutics (CARA) United States $0.712B 0.00
AVROBIO (AVRO) United States $0.704B 0.00
Vericel (VCEL) United States $0.702B 0.00
InflaRx (IFRX) Germany $0.702B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.687B 0.00
Athenex (ATNX) United States $0.684B 0.00
TWIST BIOSCIENC (TWST) United States $0.654B 0.00
UROGEN PHARMA (URGN) Israel $0.654B 0.00
Novavax (NVAX) United States $0.639B 0.00
CytomX Therapeutics (CTMX) United States $0.620B 0.00
ANI Pharmaceuticals (ANIP) United States $0.616B 11.81
AMAG Pharmaceuticals (AMAG) United States $0.588B 0.00
AC Immune SA (ACIU) Switzerland $0.582B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.578B 0.00
Gritstone Oncology (GRTS) United States $0.576B 0.00
Epizyme (EPZM) United States $0.575B 0.00
Principia Biopharma (PRNB) United States $0.572B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.567B 0.00
Scholar Rock Holding (SRRK) United States $0.558B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.533B 0.00
Arvinas (ARVN) United States $0.529B 0.00
Senesco Technologies (ELOX) United States $0.526B 0.00
UNITY Biotechnology (UBX) $0.510B 0.00
Eidos Therapeutics (EIDX) United States $0.505B 0.00
Arcus Biosciences (RCUS) United States $0.504B 0.00
Anika Therapeutics (ANIK) United States $0.503B 20.81
Kezar Life Sciences (KZR) United States $0.492B 0.00
ObsEva SA (OBSV) Switzerland $0.486B 0.00
BeyondSpring (BYSI) United States $0.483B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.468B 0.00
Inovio Pharmaceuticals (INO) United States $0.468B 0.00
Mesoblast (MESO) Australia $0.464B 0.00
Replimune (REPL) United States $0.444B 0.00
Prothena (PRTA) Ireland $0.440B 0.00
Kura Oncology (KURA) United States $0.434B 0.00
PDL BioPharma (PDLI) United States $0.425B 6.93
RA PHARMCTL INC (RARX) United States $0.421B 0.00
Sinovac Biotech (SVA) China $0.420B 0.00
Kindred Biosciences (KIN) United States $0.417B 0.00
MediciNova (MNOV) United States $0.412B 0.00
Zymeworks (ZYME) Canada $0.409B 0.00
Sorrento Therapeutics (SRNE) United States $0.402B 65.80
Five Prime Therapeutics (FPRX) United States $0.389B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.384B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.380B 0.00
Stemline Therapeutics (STML) United States $0.364B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.363B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
Abeona Therapeutics (ABEO) United States $0.360B 0.00
Zealand Pharma (ZEAL) Denmark $0.354B 0.00
Verastem (VSTM) United States $0.353B 0.00
Liquidia Technologies (LQDA) United States $0.343B 0.00
MeiraGTx Holdings (MGTX) United States $0.342B 0.00
Seres Therapeutics (MCRB) United States $0.338B 0.00
Cytokineticsorporated (CYTK) United States $0.338B 0.00
LogicBio Therapeutics (LOGC) United States $0.330B 0.00
ResTORbio (TORC) United States $0.329B 0.00
Kodiak Sciences (KOD) United States $0.316B 0.00
Krystal Biotech (KRYS) United States $0.313B 0.00
Merus (MRUS) Netherlands $0.306B 0.00
Cellular Biomedicine (CBMG) United States $0.304B 0.00
Albireo Pharma (ALBO) United States $0.299B 0.00
MannKind (MNKD) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.283B 0.00
Geron (GERN) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.274B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.270B 0.00
Equillium (EQ) United States $0.266B 0.00
Sutro Biopharma (STRO) United States $0.265B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
Celcuity (CELC) United States $0.261B 0.00
Athersys (ATHX) United States $0.259B 0.00
BioDelivery Sciences (BDSI) United States $0.253B 0.00
Syros Pharmaceuticals (SYRS) United States $0.252B 0.00
Agenus (AGEN) United States $0.247B 0.00
Arbutus Biopharma (ABUS) Canada $0.243B 0.00
Unum Therapeutics (UMRX) United States $0.240B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.239B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.237B 0.00
TOCAGEN INC (TOCA) United States $0.237B 0.00
Evelo Biosciences (EVLO) United States $0.233B 0.00
Axovant Sciences (AXON) United Kingdom $0.232B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.231B 0.00
BioTime (BTX) United States $0.229B 0.00
Strongbridge Biopharma (SBBP) United States $0.227B 0.00
Proteostasis Therapeutics (PTI) United States $0.225B 0.00
Adverum Biotechnologies (ADVM) United States $0.224B 0.00
Magenta Therapeutics (MGTA) United States $0.221B 0.00
Urovant Sciences (UROV) United States $0.217B 0.00
Kamada (KMDA) Israel $0.216B 19.83
Synlogic (SYBX) United States $0.215B 0.00
Kala Pharmaceuticals (KALA) United States $0.214B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.210B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.199B 0.00
Protagonist Therapeutics (PTGX) United States $0.197B 0.00
Idera Pharmaceuticals (IDRA) United States $0.195B 0.00
Intec Pharma (NTEC) Israel $0.191B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
ChromaDex (CDXC) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.177B 0.00
NantKwest (NK) United States $0.174B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.171B 0.00
Palatin Technologies (PTN) United States $0.169B 20.75
Compugen (CGEN) Israel $0.167B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.165B 0.00
Allena Pharmaceuticals (ALNA) United States $0.164B 0.00
Cerecor (CERC) United States $0.157B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.155B 0.00
PSivida (EYPT) United States $0.153B 0.00
Pfenex (PFNX) United States $0.149B 0.00
Menlo Therapeutics (MNLO) United States $0.149B 0.00
Constellation Pharmaceuticals (CNST) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.148B 0.00
Mersana Therapeutics (MRSN) United States $0.146B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
XBiotech (XBIT) United States $0.145B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.144B 0.00
Spero Therapeutics (SPRO) United States $0.143B 0.00
Cohbar (CWBR) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.133B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
Eleven Biotherapeutics (SESN) United States $0.124B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Catalyst Biosciences (CBIO) United States $0.123B 0.00
VBI Vaccines (VBIV) United States $0.120B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.120B 0.00
Cue Biopharma (CUE) United States $0.115B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.114B 0.00
CorMedix Inc (CRMD) United States $0.114B 0.00
XOMA (XOMA) United States $0.112B 0.00
OVID THERAPEUTC (OVID) United States $0.112B 0.00
Anavex Life Sciences (AVXL) United States $0.110B 0.00
Motif Bio Plc (MTFB) United States $0.109B 0.00
Mustang Bio (MBIO) United States $0.109B 0.00
Signal Genetics (MGEN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.107B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.101B 0.00
Provention Bio (PRVB) United States $0.098B 0.00
Chiasma (CHMA) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Orgenesis (ORGS) United States $0.090B 0.00
PHASEBIO PHARMA (PHAS) United States $0.088B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Axsome Therapeutics (AXSM) United States $0.084B 0.00
BioXcel Therapeutics (BTAI) United States $0.083B 0.00
Cocrystal Pharma (COCP) United States $0.082B 91.00
Ophthotech (OPHT) United States $0.079B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.079B 0.00
VolitionRX (VNRX) Singapore $0.077B 0.00
Checkpoint Therapeutics (CKPT) United States $0.077B 0.00
Monster Digital (INNT) United States $0.076B 0.00
Prima BioMed (IMMP) Australia $0.076B 0.00
Cel-Sci (CVM) United States $0.075B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Aptevo Therapeutics (APVO) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Versartis (ARAV) United States $0.070B 6.12
Evogene (EVGN) Israel $0.069B 0.00
NewLink Genetics (NLNK) United States $0.069B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
ITUS (ANIX) United States $0.067B 0.00
Asterias Biotherapeutics (AST) United States $0.067B 0.00
Alcobra (ARCT) United States $0.066B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Celldex Therapeutics (CLDX) United States $0.057B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.056B 9.00
Bellerophon Therapeutics (BLPH) United States $0.055B 0.00
Sophiris Bio (SPHS) United States $0.055B 0.00
Leap Therapeutics (LPTX) United States $0.053B 0.00
Oncobiologics (ONS) United States $0.053B 0.00
Trevena (TRVN) United States $0.052B 0.00
OncoSec Medical (ONCS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Clearside Biomedical (CLSD) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Oncolytics Biotech (ONCY) Canada $0.047B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.045B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.041B 0.00
AEterna Zentaris (AEZS) United States $0.040B 7.59
TRACON Pharmaceuticals (TCON) United States $0.039B 0.00
AquaBounty Technologies (AQB) United States $0.039B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.034B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
VIVUS (VVUS) United States $0.034B 0.00
GTx (GTXI) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Proteon Therapeutics (PRTO) United States $0.030B 0.00
Therapix Biosciences (TRPX) Israel $0.028B 10.27
Vical (VICL) United States $0.027B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Advaxis (ADXS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
OvaScience (OVAS) United States $0.024B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
CytRx (CYTR) United States $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
GENPREX INC (GNPX) United States $0.020B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
Arsanis (ASNS) United States $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.016B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Histogenics (HSGX) United States $0.012B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Oragenics (OGEN) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00